semaglutide and muscle mass (GLP-1) Loss: Body Composition Changes Findings Beneficial effects of liraglutide and

Sustained outcomes Ongoing medication management and provider monitoring help maintain results beyond the initial weight loss phase

[DOI] [PubMed] [Google Scholar] 281.Umpierrez G., et al

Available in injectable form (Ozempic) for diabetes management and oral formulation (Rybelsus) for both diabetes and as a separate injectable dose (Wegovy) for obesity, semaglutide offers flexibility and convenience to meet diverse patient needs

Changes in appetite and high-calorie intake also reverse the metabolic benefits of semaglutide, which disrupts insulin regulation and blood sugar control

In 2021, China had 141 million people with diabetes, projected to rise to 164 million by 2030 the highest globally, according to the International Diabetes Federation

As retatrutide has not yet received MHRA or EMA approval, it does not currently have a published SmPC